論文

査読有り
2018年1月10日

The role of cysteine string protein α phosphorylation at serine 10 and 34 by protein kinase Cγ for presynaptic maintenance

Journal of Neuroscience
  • Toshihiko Shirafuji
  • Takehiko Ueyama
  • Naoko Adachi
  • Ken-Ichi Yoshino
  • Yusuke Sotomaru
  • Junsuke Uwada
  • Azumi Kaneoka
  • Taro Ueda
  • Shigeru Tanaka
  • Izumi Hide
  • Naoaki Saito
  • Norio Sakai
  • 全て表示

38
2
開始ページ
278
終了ページ
290
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1523/JNEUROSCI.1649-17.2017
出版者・発行元
Society for Neuroscience

Protein kinase Cγ (PKCγ) knock-out (KO) animals exhibit symptoms of Parkinson’s disease (PD), including dopaminergic neuronal loss in the substantia nigra. However, the PKCγ substrates responsible for the survival of dopaminergic neurons in vivo have not yet been elucidated. Previously, we found 10 potent substrates in the striatum of PKCγ-KO mice. Here, we focused on cysteine string protein α (CSPα), a protein from the heat shock protein (HSP) 40 cochaperone families localized on synaptic vesicles. We found that in cultured cells, PKCγ phosphorylates CSPα at serine (Ser) 10 and Ser34. Additionally, apoptosis was found to have been enhanced by the overexpression of a phosphorylation-null mutant of CSPα, CSPα(S10A/S34A). Compared with wild-type (WT) CSPα, the CSPα(S10A/S34A) mutant had a weaker interaction with HSP70. However, in sharp contrast, a phosphomimetic CSPα(S10D/S34D) mutant, compared with WT CSPα, had a stronger interaction with HSP70. In addition, total levels of synaptosomal-associated protein (SNAP) 25, a main downstream target of the HSC70/HSP70 chaperone complex, were found to have decreased by the CSPα(S10A/S34A) mutant through increased ubiquitination of SNAP25 in PC12 cells. In the striatum of 2-year-old male PKCγ-KO mice, decreased phosphorylation levels of CSPα and decreased SNAP25 protein levels were observed. These findings indicate the phosphorylation of CSPα by PKCγ may protect the presynaptic terminal from neurodegeneration. The PKCγ–CSPα–HSC70/HSP70–SNAP25 axis, because of its role in protecting the presynaptic terminal, may provide a new therapeutic target for the treatment of PD.

リンク情報
DOI
https://doi.org/10.1523/JNEUROSCI.1649-17.2017
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/29167402
Scopus
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85040531341&origin=inward
Scopus Citedby
https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85040531341&origin=inward
ID情報
  • DOI : 10.1523/JNEUROSCI.1649-17.2017
  • ISSN : 1529-2401
  • ISSN : 0270-6474
  • eISSN : 1529-2401
  • PubMed ID : 29167402
  • SCOPUS ID : 85040531341

エクスポート
BibTeX RIS